Assessment of Low-dose ASA Discontinuation Risk Associated With Concomitant PPI Use During the First Year of ASA Therapy

NCT01888575 · clinicaltrials.gov ↗

COMPLETED

Status

35604

Enrollment

INDUSTRY

Sponsor class

Conditions

Cardiovascular Prevention

Interventions

DRUG: Risk of low dose aspirin discontinuation

Sponsor

AstraZeneca